Characteristics | Overall | Control group | Case group | P-value |
---|---|---|---|---|
N | 60 (100%) | 48 (80%) | 12 (20%) | Â |
Age, years | 66.0 (60.0, 70.0) | 65.0 (58.0, 70.0) | 69.0 (65.8, 73.2) | 0.095 |
Sex | Â | Â | Â | Â |
Female | 40 (66.7%) | 32 (66.7%) | 8 (66.7%) |  > 0.999 |
Male | 20 (33.3%) | 16 (33.3%) | 4 (33.3%) | Â |
Vaccine status | Â | Â | Â | Â |
Unvaccinated | 5 (8.3%) | 2 (4.2%) | 3 (25.0%) | 0.049 |
Vaccinated | 55 (91.7%) | 46 (95.8%) | 9 (75.0%) | Â |
Dose | Â | Â | Â | Â |
0 | 5 (8.3%) | 2 (4.2%) | 3 (25.0%) | 0.172 |
1 | 1 (1.7%) | 1 (2.1%) | 0 (0.0%) | Â |
2 | 52 (86.7%) | 43 (89.6%) | 9 (75.0%) | Â |
3 | 2 (3.3%) | 2 (4.2%) | 0 (0.0%) | Â |